Drugs / standard inactivated influenza vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00307710 | Aug 2004 → Feb 2007 | lymphoma | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | standard inactivated influenza vaccine | “Receive either standard inactivated influenza vaccine or one of three doses of the experimental vaccine, vaccine dose 15, 45 or 135 μg HA per virus, intramuscular injection.” NCT00307710 ↗ |
| Modality | Vaccine | “standard inactivated influenza vaccine” NCT00307710 ↗ |
| Route | Intramuscular | “standard inactivated influenza vaccine by intramuscular injection” NCT00307710 ↗ |